<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
69438-0014-1
</NDCCode>
<PackageDescription>
5 L in 1 BOTTLE (69438-0014-1)
</PackageDescription>
<NDC11Code>
69438-0014-01
</NDC11Code>
<ProductNDC>
69438-0014
</ProductNDC>
<ProductTypeName>
DRUG FOR FURTHER PROCESSING
</ProductTypeName>
<ProprietaryName/>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Lebrikizumab
</NonProprietaryName>
<DosageFormName>
LIQUID
</DosageFormName>
<RouteName/>
<StartMarketingDate>
20260331
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
DRUG FOR FURTHER PROCESSING
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
LONZA BIOLOGICS TUAS PTE. LTD.
</LabelerName>
<SubstanceName>
LEBRIKIZUMAB
</SubstanceName>
<StrengthNumber>
125
</StrengthNumber>
<StrengthUnit>
g/L
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Unfinished
</Status>
<LastUpdate>
2026-03-31
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough/>
<StartMarketingDatePackage>
31-MAR-26
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>